Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2025
    • The 2024 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Podcasts
    • Print Subscription
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Video
  • 2025 Leadership
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe

Sanofi Divests Dermik Dermatology Unit to Valeant Pharmaceuticals International, Inc.

July 11, 2011 By Bio-Medicine.Org

PARIS, July 11, 2011 /PRNewswire/ — Sanofi (EURONEXT: SAN and
NYSE:
SNY
) announced today the strategic divestiture of its
dermatology business, Dermik, to Valeant Pharmaceuticals
International Inc. (NYSE/TSX: VRX) (“Valeant”), for a total cash
consideration of US $425 million. Valeant is a pharmaceutical
company focused on the neurology and dermatology therapeutic areas,
based in Mississauga, Ontario, Canada.

(Logo:
http://photos.prnewswire.com/prnh/20110616/NY20158LOGO)

Dermik has a significant presence in the medical dermatology
market in the United States and Canada with a strong field force
and well-known brands. Dermik’s portfolio includes leading
therapeutic and aesthetic dermatology brands such as BenzaClin®
for the treatment of acne, Carac® for the treatment of
keratoses and Sculptra®, a facial injectable for the correction
of facial wrinkles and folds.

The scope of this transaction includes Dermik assets, which
consist of an aesthetic and therapeutic business in the United
States and Canada, as well as an aesthetic business around the
world with sales of US $206 million in 2010. Also included in the
scope is Sanofi’s Laval, Canada site, which includes Dermik’s
manufacturing facility.  Sanofi’s Canadian affiliate,
sanofi-aventis Canada, will maintain its operations in greater
Montreal.

Sanofi decided to divest its dermatology business with the
intention to further concentrate on its growth platforms. Sanofi
believes that Dermik will benefit from being part of a larger
dermatology business.

Commenting on the agreement, Christopher A. Viehbacher, Chief
Executive Officer of Sanofi, said: “Our strategy is based upon
our growth platforms and innovation. This divestiture allows us to
rationalize our portfolio and improve focus on our core businesses.
Our manufacturing operations in Laval and our field operations
teams will

‘/>”/>

SOURCE

Related Articles Read More >

How this device broke through the blood-brain barrier
A photo of the miniature Auxilium Biotechnologies implants made on the International Space Station.
Implants 3D-printed in space could enable nerve regeneration
An illustration showing the Artedrone Sasha thrombectomy catheter approaching a blood clot.
This microrobot system is designed to float inside a stroke patient for autonomous thrombectomy
A photo of nitinol, a nickel-titanium alloy used for medical devices such as stents, heart valves, catheters and orthopedics.
What is nitinol and where is it used?
“mdo
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest medical device business news, application and technology trends.

DeviceTalks Weekly

See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech100 Index
  • Medical Tubing + Extrusion
  • Medical Design Sourcing
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to our E-Newsletter
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2025 WTWH Media, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2025
    • The 2024 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Podcasts
    • Print Subscription
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Video
  • 2025 Leadership
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe